Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.60 |
| ▸ | ACHE | P22303 | 6/20 | 0.52 |
| ▸ | TSHR | P16473 | 3/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | ESR1 | P03372 | 2/20 | 0.46 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | ACP3 | P15309 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL50087 | 1.00 | TDP1 (0.60) | TDP1CYP3A4ACHETSHRLMNA | |
| SCHEMBL29535020 | 1.00 | TDP1 (0.60) | TDP1CYP3A4ACHETSHRLMNA | |
| SCHEMBL29415924 | 0.92 | ACHE (0.61) | TDP1CYP3A4ACHETSHRLMNA | |
| SCHEMBL49786 | 0.92 | ACHE (0.61) | TDP1CYP3A4ACHETSHRLMNA | |
| SCHEMBL18423870 | 0.90 | ACHE (0.58) | TDP1CYP3A4ACHETSHRLMNA | |
| Bromide SCHEMBL8849644 | 0.90 | ACHE (0.58) | TDP1CYP3A4ACHETSHRLMNA | |
| Hydrochloric Acid SCHEMBL4529394 | 0.90 | ACHE (0.58) | TDP1CYP3A4ACHETSHRLMNA | |
| SCHEMBL5713327 | 0.90 | ACHE (0.58) | TDP1CYP3A4ACHETSHRLMNA | |
| SCHEMBL8849287 | 0.90 | ACHE (0.58) | TDP1CYP3A4ACHETSHRLMNA | |
| Hydrochloric Acid SCHEMBL29001481 | 0.90 | ACHE (0.58) | TDP1CYP3A4ACHETSHRLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108003092-B | Synthetic method of 2, 3-dichloropyridine | 重庆中邦科技有限公司 | 2021-04-02 | — | — | CN | claimed |
| CN-108003092-B | Synthetic method of 2, 3-dichloropyridine | 重庆中邦科技有限公司 | 2021-04-02 | — | — | CN | disclosed |
| US-20180244865-A1 | INCREASED EFFICIENCY DESULFURIZATION REAGENTS | ARLANXEO DEUTSCHLAND GMBH (DE) | 2018-08-30 | — | — | US | disclosed |
| EP-3341432-A1 | INCREASED EFFICIENCY DESULFURIZATION REAGENTS | ARLANXEO Deutschland GmbH (DE) | 2018-07-04 | — | — | EP | disclosed |
| WO-2017036721-A1 | INCREASED EFFICIENCY DESULFURIZATION REAGENTS | ARLANXEO DEUTSCHLAND GMBH (DE) | 2017-03-09 | — | — | WO | disclosed |
| EP-3135712-A1 | INCREASED EFFICIENCY OF DESULFURIZATION REAGENTS | ARLANXEO Deutschland GmbH (DE) | 2017-03-01 | — | — | EP | disclosed |
| US-20130042972-A1 | Dual Cure Thermally Conductive Adhesive | THE BERGQUIST COMPANY | 2013-02-21 | — | — | US | disclosed |
| WO-2013025849-A1 | DUAL CURE THERMALLY CONDUCTIVE ADHESIVE | THE BERGQUIST COMPANY (US) | 2013-02-21 | — | — | WO | disclosed |
| US-8129467-B2 | Curing accelerating compound-silica composite material, method for producing curing accelerating compound-silica composite material, curing accelerator, curable resin composition, and electronic component device | HITACHI CHEMICAL CO., LTD. (JP) | 2012-03-06 | — | — | US | disclosed |
| US-20090062460-A1 | CURING ACCELERATING COMPOUND-SILICA COMPOSITE MATERIAL, METHOD FOR PRODUCING CURING ACCELERATING COMPOUND-SILICA COMPOSITE MATERIAL, CURING ACCELERATOR, CURABLE RESIN COMPOSITION, AND ELECTRONIC COMPONENT DEVICE | HITACHI CHEMICAL CO., LTD. (JP) | 2009-03-05 | — | — | US | disclosed |
| US-6825280-B1 | RIGIDITY, NONWARPING, NONBLEEDING, ANTISTATIC AGENTS, WEATHERPROOF, IMPACT STRENGTH; OXIDATION AND HEAT RESISTANCE | JAPAN POLYCHEM CORPORATION (JP) | 2004-11-30 | — | — | US | disclosed |
| EP-1002814-A1 | PROPYLENE BLOCK COPOLYMER AND PROPYLENE RESIN COMPOSITION | Japan Polychem Corporation (JP) | 2000-05-24 | — | — | EP | disclosed |
| US-4257973-A | USING ORGANOPHOSPHORUS-PALLADIUM HALIDE COORDINATION CATALYST | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1981-03-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090062460-A1 | CURING ACCELERATING COMPOUND-SILICA COMPOSITE MATERIAL, METHOD FOR PRODUCING CURING ACCELERATING COMPOUND-SILICA COMPOSITE MATERIAL, CURING ACCELERATOR, CURABLE RESIN COMPOSITION, AND ELECTRONIC COMPONENT DEVICE | NCAPH, RAD51, H1-2 | TDP1 2981/4885CYP3A4 3968/4885ACHE 3068/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.